A 139 (Fenofibric Acid Delayed-Release 135 mg)
Pill with imprint A 139 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric acid delayed-release 135 mg. It is supplied by Alembic Pharmaceuticals Inc..
Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for A 139
Fenofibric acid delayed-release
- Imprint:
- A 139
- Strength:
- 135 mg
- Color:
- Blue & Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Alembic Pharmaceuticals Inc.
- National Drug Code (NDC):
- 62332-0245
More about fenofibric acid
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 24 Reviews – Add your own review/rating
- Drug class: fibric acid derivatives
Consumer resources
Other brands: Trilipix, Fibricor
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
